Most patients with rheumatoid arthritis (RA) treated with upadacitinib and methotrexate had robust antibody and T-cell responses to the recombinant zoster vaccine (Shingrix; GSK), according to 60-week ...

Dynavax Technologies has revealed promising topline outcomes from the initial part of its Phase I/II clinical trial, ...

Inflammation supports selection, differentiation bias, and epigenetic reprogramming of hematopoietic stem and progenitor cells to generate innate immune memory.